A blueprint for tumor-infiltrating B cells across human cancers

• Published in: Science (American Association for the Advancement of Science) 2024-05, Vol.384 (6695), p.eadj4857-eadj4857
• Main Authors: Ma, Jiaqiang, Wu, Yingcheng, Ma, Lifeng, Yang, Xupeng, Zhang, Tiancheng, Song, Guohe, Li, Teng, Gao, Ke, Shen, Xia, Lin, Jian, Chen, Yamin, Liu, Xiaoshan, Fu, Yuting, Gu, Xixi, Chen, Zechuan, Jiang, Shan, Rao, Dongning, Pan, Jiaomeng, Zhang, Shu, Zhou, Jian, Huang, Chen, Shi, Si, Fan, Jia, Guo, Guoji, Zhang, Xiaoming, Gao, Qiang
• Format: Article
• Language: English
• Subjects: Accessibility; Adenocarcinoma; Antibodies; Antitumor activity; B-cell receptor; B-Lymphocytes - immunology; Cancer; Cell differentiation; Cells; Chromatin; Colon cancer; Differentiation (biology); Epigenesis, Genetic; Epigenetics; Feedback (Response); Gene expression; Gene sequencing; Germinal Center - immunology; Germinal centers; Glutamine; Hepatocellular carcinoma; Heterogeneity; Humans; Immune response (humoral); Immunity, Humoral; Immunological memory; Immunoregulation; Immunosuppression; Immunotherapy; Individualized Instruction; Leukocytes; Lymphocytes; Lymphocytes B; Lymphocytes T; Lymphocytes, Tumor-Infiltrating - immunology; Metabolism; Metabolites; Metastases; Neoplasms - genetics; Neoplasms - immunology; Neoplasms - therapy; Networks; Patients; Phenotypes; Rapamycin; Receptors; Receptors, Antigen, B-Cell - genetics; Receptors, Antigen, B-Cell - immunology; Receptors, Antigen, B-Cell - metabolism; Signal transduction; Single-Cell Analysis; T-Lymphocytes - immunology; Transcription factors; Transcriptome; Tumors
• ISSN: 0036-8075; 1095-9203
• DOI: 10.1126/science.adj4857

B lymphocytes are essential mediators of humoral immunity and play multiple roles in human cancer. To decode the functions of tumor-infiltrating B cells, we generated a B cell blueprint encompassing single-cell transcriptome, B cell-receptor repertoire, and chromatin accessibility data across 20 different cancer types (477 samples, 269 patients). B cells harbored extraordinary heterogeneity and comprised 15 subsets, which could be grouped into two independent developmental paths (extrafollicular versus germinal center). Tumor types grouped into the extrafollicular pathway were linked with worse clinical outcomes and resistance to immunotherapy. The dysfunctional extrafollicular program was associated with glutamine-derived metabolites through epigenetic-metabolic cross-talk, which promoted a T cell-driven immunosuppressive program. These data suggest an intratumor B cell balance between extrafollicular and germinal-center responses and suggest that humoral immunity could possibly be harnessed for B cell-targeting immunotherapy.